Cargando…
MD-Miner: a network-based approach for personalized drug repositioning
BACKGROUND: Due to advances in next generation sequencing technologies and corresponding reductions in cost, it is now attainable to investigate genome-wide gene expression and variants at a patient-level, so as to better understand and anticipate heterogeneous responses to therapy. Consequently, it...
Autores principales: | Wu, Haoyang, Miller, Elise, Wijegunawardana, Denethi, Regan, Kelly, Payne, Philip R.O., Li, Fuhai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5629618/ https://www.ncbi.nlm.nih.gov/pubmed/28984195 http://dx.doi.org/10.1186/s12918-017-0462-9 |
Ejemplares similares
-
Integrative network and transcriptomics-based approach predicts genotype- specific drug combinations for melanoma
por: Regan, Kelly E., et al.
Publicado: (2017) -
Sequence Determinants of TDP-43 Ribonucleoprotein Condensate Formation and Axonal Transport in Neurons
por: Vishal, Sonali S., et al.
Publicado: (2022) -
Drug repositioning for personalized medicine
por: Li, Yvonne Y, et al.
Publicado: (2012) -
Network mirroring for drug repositioning
por: Park, Sunghong, et al.
Publicado: (2017) -
System and network biology-based computational approaches for drug repositioning
por: Pandita, Vasundhara, et al.
Publicado: (2022)